Immune responses to oral poliovirus vaccine in HIV-exposed uninfected Zimbabwean infants

References

• Evans C, Jones CE, Prendergast AJ. HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. Lancet Infect Dis. 2016;16(6):e92-e107. doi:10.1016/S1473-3099(16)00055-4. PMID:27049574
   PubMedGoogle Scholar
• Filteau S. The HIV-exposed, uninfected African child. Trop Med Int Health. 2009;14(3):276-87. doi:10.1111/j.1365-3156.2009.02220.x. PMID:19171011
   PubMed Web of Science ®Google Scholar
• Bernstein LJ, Ochs HD, Wedgwood RJ, Rubinstein A. Defective humoral immunity in pediatric acquired immune deficiency syndrome. J Pediatr. 1985;107(3):352-7. doi:10.1016/S0022-3476(85)80505-9. PMID:4032129
   PubMed Web of Science ®Google Scholar
• Shearer, WT, Easley KA, Goldfarb J, Rosenblatt HM, Jenson HB, Kovacs A, McIntosh K. Prospective 5-year study of peripheral blood CD4, CD8, and CD19/CD20 lymphocytes and serum Igs in children born to HIV-1 women. The P(2)C(2) HIV Study Group. J Allergy Clin Immunol. 2000;106(3):559-66. doi:10.1067/mai.2000.109433. PMID:10984378
   PubMed Web of Science ®Google Scholar
• Afran L, Garcia Knight M, Nduati E, Urban BC, Heyderman RS, Rowland-Jones SL. HIV-exposed uninfected children: a growing population with a vulnerable immune system? Clin Exp Immunol. 2014;176(1):11-22. doi:10.1111/cei.12251. PMID:24325737
   PubMed Web of Science ®Google Scholar
• Polio Eradication & Endgame Strategic Plan 2013-2018; Polio Global Eradication Initiative. Geneva: World Health Organisation; 2013 [accessed 2016 Nov 8]. Available at: http://polioeradication.org/wp-content/uploads/2016/07/PEESP_EN_A4.pdf
   Google Scholar
• Patriarca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis. 1991;13(5):926-39. doi:10.1093/clinids/13.5.926. PMID:1660184
   PubMedGoogle Scholar
• Grassly NC, Jafari H, Bahl S, Durrani S, Wenger J, Sutter RW, Bruce Aylward R. Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination. J Infect Dis. 2010;201(10):1535-43. doi:10.1086/651952. PMID:20367459
   PubMed Web of Science ®Google Scholar
• Haque R, Snider C, Liu Y, Ma JZ, Liu L, Nayak U, Mychaleckyj JC, Korpe P, Mondal D, Kabir M, et al. Oral polio vaccine response in breast fed infants with malnutrition and diarrhea. Vaccine. 2014;32(4):478-82. doi:10.1016/j.vaccine.2013.11.056. PMID:24300591
   PubMed Web of Science ®Google Scholar
• Maldonado YA, Peña-Cruz V, de la Luz Sanchez M, Logan L, Blandón S, Cantwell MF, Matsui SM, Millan-Velasco F, Valdespino JL, Sepulveda J. Host and viral factors affecting the decreased immunogenicity of Sabin type 3 vaccine after administration of trivalent oral polio vaccine to rural Mayan children. J Infect Dis. 1997;175(3):545-53. doi:10.1093/infdis/175.3.545. PMID:9041324
   PubMed Web of Science ®Google Scholar
• Posey DL, Linkins RW, Oliveria MJ, Monteiro D, Patriarca PA. The effect of diarrhea on oral poliovirus vaccine failure in Brazil. J Infect Dis. 1997;175 Suppl 1:S258-63. doi:10.1093/infdis/175.Supplement_1.S258. PMID:9203726
   PubMed Web of Science ®Google Scholar
• Triki H, Abdallah MV, Ben Aissa R, Bouratbine A, Ben Ali Kacem M, Bouraoui S, Koubaa C, Zouari S, Mohsni E, Crainic R, et al. Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants. Vaccine. 1997;15(10):1123-9. doi:10.1016/S0264-410X(97)00001-7. PMID:9269056
   PubMed Web of Science ®Google Scholar
• Naylor C, Lu M, Haque R, Mondal D, Buonomo E, Nayak U, Mychaleckyj JC, Kirkpatrick B, Colgate R, Carmolli M, et al. Environmental enteropathy, oral vaccine failure and growth faltering in infants in Bangladesh. EBioMedicine. 2015;2(11):1759-66. doi:10.1016/j.ebiom.2015.09.036. PMID:26870801
   PubMed Web of Science ®Google Scholar
• Troy SB, Musingwini G, Halpern MS, Huang C, Stranix-Chibanda L, Kouiavskaia D, Shetty AK, Chumakov K, Nathoo K, Maldonado YA. Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants. J Infect Dis. 2013;208(4):672-8. doi:10.1093/infdis/jit208. PMID:23661792
   PubMed Web of Science ®Google Scholar
• Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA. 2011;305(6):576-84. doi:10.1001/jama.2011.100. PMID:21304083
   PubMed Web of Science ®Google Scholar
• Madhi SA, Izu A, Violari A, Cotton MF, Panchia R, Dobbels E, Sewraj P, van Niekerk N, Jean-Philippe P, Adrian PV. Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and -uninfected infants. Vaccine. 2013;31(5):777-83. doi:10.1016/j.vaccine.2012.11.076. PMID:23228814
   PubMed Web of Science ®Google Scholar
• Reikie BA, Naidoo S, Ruck CE, Slogrove AL, de Beer C, la Grange H, Adams RC, Ho K, Smolen K, Speert DP, et al., Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the First 2 years of life. Clin Vaccine Immunol. 2013;20(1):33-8. doi:10.1128/CVI.00557-12. PMID:23114697
   PubMed Web of Science ®Google Scholar
• Simani OE, Izu A, Violari A, Cotton MF, van Niekerk N, Adrian PV, Madhi SA. Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy. Aids. 2014;28(4):531-41. doi:10.1097/QAD.0000000000000127. PMID:24468996
   PubMed Web of Science ®Google Scholar
• Miles DJ, Gadama L, Gumbi A, Nyalo F, Makanani B, Heyderman RS. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guerin (BCG) vaccine in HIV-uninfected infants. Immunology. 2010;129(3):446-54. doi:10.1111/j.1365-2567.2009.03186.x. PMID:20002789
   PubMed Web of Science ®Google Scholar
• Sanz-Ramos M, Manno D, Kapambwe M, Ndumba I, Musonda KG, Bates M, Chibumbya J, Siame J, Monze M, Filteau S, et al. Reduced Poliovirus vaccine neutralising-antibody titres in infants with maternal HIV-exposure. Vaccine. 2013;31(16):2042-9. doi:10.1016/j.vaccine.2013.02.044. PMID:23474309
   PubMed Web of Science ®Google Scholar
• Tejiokem MC, Gouandjika I, Béniguel L, Zanga MC, Tene G, Gody JC, Njamkepo E, Kfutwah A, Penda I, Bilong C, et al. HIV-Infected children living in Central Africa have low persistence of antibodies to vaccines used in the expanded program on immunization. Plos One. 2007;2(12):e1260. doi:10.1371/journal.pone.0001260. PMID:18060056
   PubMed Web of Science ®Google Scholar
• Koyanagi A, Humphrey JH, Ntozini R, Nathoo K, Moulton LH, Iliff P, Mutasa K, Ruff A, Ward B. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J. 2011;30(1):45-51. doi:10.1097/INF.0b013e3181ecbf7e. PMID:21173675
   PubMed Web of Science ®Google Scholar
• Gaensbauer JT, Rakhola JT, Onyango-Makumbi C, Mubiru M, Westcott JE, Krebs NF, Asturias EJ, Fowler MG, McFarland E, Janoff EN. Impaired Haemophilus influenzae Type b Transplacental antibody transmission and declining antibody avidity through the first year of life represent Potential Vulnerabilities for HIV-Exposed but - uninfected infants. Clin Vaccine Immunol. 2014;21(12):1661-7. doi:10.1128/CVI.00356-14. PMID:25298109
   PubMed Web of Science ®Google Scholar
• Marinda E, Humphrey JH, Iliff PJ, Mutasa K, Nathoo KJ, Piwoz EG, Moulton LH, Salama P, Ward BJ. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J. 2007;26(6):519-26. doi:10.1097/01.inf.0000264527.69954.4c. PMID:17529870
   PubMed Web of Science ®Google Scholar
• Gibson RS. Principles of Nutritional Assessment. Second ed. Oxford, UK: Oxford University Press; 1990. p. 712.
   Google Scholar
• Iliff PJ, Piwoz EG, Tavengwa NV, Zunguza CD, Marinda ET, Nathoo KJ, Moulton LH, Ward BJ, Humphrey JH. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS. 2005;19(7):699-708. doi:10.1097/01.aids.0000166093.16446.c9. PMID:15821396
   PubMed Web of Science ®Google Scholar
• WHO Immunization coverage: reported coverage by country, year and vaccine. 15th July 2016 24th October 2016]; Immunization coverage per country, year and disease dating back to 1980]. Available from: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tscoveragebcg.html.
   Google Scholar
• Ivanov AP, Dragunsky EM. ELISA as a possible alternative to the neutralization test for evaluating the immune response to poliovirus vaccines. Expert Rev Vaccines. 2005;4(2):167-72. doi:10.1586/14760584.4.2.167. PMID:15889990
   PubMed Web of Science ®Google Scholar
• Simhon A, Lifshitz A, Abed Y, Lasch EE, Schoub B, Morag A. How to Predict the Immune Status of Poliovirus Vaccinees - a Comparison of Virus Neutralization at a Very Low Serum Dilution Versus Elisa in a Cohort of Infants. Int J Epidemiol. 1990;19(1):164-8. doi:10.1093/ije/19.1.164. PMID:2161806
   PubMed Web of Science ®Google Scholar
• Gary BE, Freeman C, Peñaranda S, Maher K, Anderson L, Pallansch MA. Comparison of a monoclonal antibody-based IgM capture ELISA with a neutralization assay for assessing response to trivalent oral poliovirus vaccine. J Infect Dis. 1997;175:S264-7. doi:10.1093/infdis/175.Supplement_1.S264. PMID:9203727
   PubMed Web of Science ®Google Scholar
• Hashido M, Horie H, Abe S, Doi Y, Hashizume S, Agboatwalla M, Isomura S, Nishio O, Hagiwara A, Inouye S. Evaluation of an enzyme-linked immunosorbent assay based on binding inhibition for type-specific quantification of poliovirus neutralization-relevant antibodies. Microbiol Immunol. 1999;43(1):73-7. doi:10.1111/j.1348-0421.1999.tb02375.x. PMID:10100750
   PubMed Web of Science ®Google Scholar
• Herremans T, Kimman TG, Conyn-Van Spaendonck MA, Buisman A, de Melker H, Abbink F, Bijkerk P, Koopmans MP. Immunoglobulin A as a serological marker for the (silent) circulation of poliovirus in an inactivated poliovirus-vaccinated population. Clin Infect Dis. 2002;34(8):1067-75. doi:10.1086/339489. PMID:11914995
   PubMed Web of Science ®Google Scholar
• Wright PF, Wieland-Alter W, Ilyushina NA, Hoen AG, Arita M, Boesch AW, Ackerman ME, van der Avoort H, Oberste MS, Pallansch MA, et al. Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination. J Infect Dis. 2014;209(10):1628-34. doi:10.1093/infdis/jit671. PMID:24459191
   PubMed Web of Science ®Google Scholar
• Smith DJ, Gahnberg L, Taubman MA, Ebersole JL. Salivary antibody responses to oral and parenteral vaccines in children. J Clin Immunol. 1986;6(1):43-9. doi:10.1007/BF00915363. PMID:3958136
   PubMed Web of Science ®Google Scholar
• Hird TR, Grassly NC. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog. 2012;8(4):e1002599. doi:10.1371/journal.ppat.1002599. PMID:22532797
   PubMed Web of Science ®Google Scholar
• Weldon WC, Oberste MS, Pallansch MA. Standardized methods for detection of poliovirus antibodies. Methods Mol Biol. 2016;1387:145-76. doi:10.1007/978-1-4939-3292-4_8
   PubMedGoogle Scholar